Abstract
Abstract Toll like receptor (TLR) pathway plays a major role in inflammatory arthritis. MicroRNA (miR)-146a, miR-155, miR-21 regulate downstream molecules of TLR signaling like IRAK-1 and TRAF-6. TLR pathway genes are generally upregulated in ERA-JIA. We studied expression of miR-146a, miR-155, miR-21, miR-210 and miR-26a in PBMC and SFMC of patients with ERA. RNA was isolated from PBMC (n=21) & SFMC (n=11) of ERA patients and PBMC of controls (n=11). The miRNA and target gene expressions were analysed by TaqMan qRT-PCR assays. Among 21 patients, 20 were boys. Mean disease onset age was 10.3Y & disease duration was 6Y. All had arthritis, 14 had enthesitis, 4 had uveitis, 7 had IBP and 2 had family history of HLAB27 related disease. No expression difference was seen in miR-146a, miR-155, miR-210 and miR-26a in PBMC of patients and controls but miR-21 was increased in patients. To check inflammatory site specific expression, comparison of SFMC and PBMC was done showing downregulation of miR146a and upregulation of miR-155, miR-21 and miR-210 in SFMC. Expression of miR-26a did not show any change. MiR-146a target genes i.e. IRAK-1 and TRAF-6 were upregulated in SFMC compared to PBMC. There is dysregulation of miRNAs regulating TLR pathway in mononuclear cells of patients with ERA-JIA especially at the chronic inflammation site. Down regulation of miR-146a, a key regulator may lead to over-expression of TLR downstream molecules like IRAK-1 and TRAF-6 thus perpetuating inflammation in ERA.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.